4,4,5,5,5-Pentafluoro-1-pentanol , 95% , 148043-73-6
CAS NO.:148043-73-6
Empirical Formula: C5H7F5O
Molecular Weight: 178.1
MDL number: MFCD00153224
EINECS: 421-360-9
Pack Size | Price | Stock | Quantity |
1g | RMB47.20 | In Stock |
|
5G | RMB142.40 | In Stock |
|
25G | RMB520.00 | In Stock |
|
others | Enquire |
PRODUCT Properties
Boiling point: | 62-64 °C35 mm Hg(lit.) |
Density | 1.35 g/mL at 25 °C(lit.) |
vapor pressure | 1.1-155.2hPa at 25-80.3℃ |
refractive index | n |
Flash point: | 145 °F |
storage temp. | 2-8°C |
solubility | Chloroform |
pka | 14.77±0.10(Predicted) |
form | Liquid |
color | Clear colorless |
InChI | InChI=1S/C5H7F5O/c6-4(7,2-1-3-11)5(8,9)10/h11H,1-3H2 |
InChIKey | QROUUECTKRZFHF-UHFFFAOYSA-N |
SMILES | C(O)CCC(F)(F)C(F)(F)F |
LogP | 1.59 at 25℃ and pH7 |
CAS DataBase Reference | 148043-73-6(CAS DataBase Reference) |
EPA Substance Registry System | 3-(Perfluoroethyl)propanol (148043-73-6) |
Description and Uses
4,4,5,5,5-Pentafluoro-1-pentanol (PFP; Pentafluoropentanol) is an essential building block primarily used in the commercial manufacture of the API. It is typically activated with a sulfonate leaving group and displaced selectively by the sulfur atom in 9-mercapto-1-nonanol to make 9-[(4,4,5,5,5-pentafluoropentyl)-thio]-1-nonanol (FVS). FVS is subsequently converted into a bromide and coupled with the steroid portion to make fulvestrant. First approved by the FDA in 2002, fulvestrant is a medication used to treat hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women with disease progression.
4,4,5,5,5-Pentafluoro-1-pentanol may be used in the preparation of chlorine-capped telechelic poly(methyl methacrylate)s.
Safety
Symbol(GHS) | GHS07 |
Signal word | Warning |
Hazard statements | H319 |
Precautionary statements | P305+P351+P338 |
Hazard Codes | Xi,F |
Risk Statements | 36-36/37/38 |
Safety Statements | 26-36 |
RIDADR | 1993 |
WGK Germany | 2 |
Hazard Note | Irritant |
HazardClass | FLAMMABLE |
HS Code | 29055900 |